Hospital de Sant Pau i Santa Tecla de Tarragona   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Tarragona Spain (1171)

Organization Overview

First Clinical Trial
2004
NCT01119430
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital de Sant Pau | Sant Pau i Santa Tecla Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Colorectal Neoplasms (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis, Alcoholic (Phase 2)

HIV Infections (Phase 4)

Mental Disorders (Phase 4)

Problem Behavior (Phase 4)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 15